EPA-Approved SARS-CoV-2 Disinfectants
3 rows where Active_ingredient contains "Sodium chlorite" and Why_on_List_N = "Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim"
json
Export this Data | Chart Risk Level by Product
Clear Chart
Add More Filters: Risk_level, Use_site, Surface_type, Formulation_type, Date_on_List_N
Active_ingredient (array)
✖
Why_on_List_N
✖
- Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim · 3 ✖
|
ID ▼
|
EPA_reg_num
|
Risk_level
|
Active_ingredient
|
Product_name
|
Company
|
Use_site
|
Surface_type
|
Contact_time
|
Formulation_type
|
Follow_directions_for_this_virus
|
Date_on_List_N
|
Why_on_List_N
|
| 1189 |
70060-19 |
Increased Risk |
Sodium chlorite; Sodium dichloroisocyanurate dihydrate |
Aseptrol S10-Tab |
BASF Corporation |
Healthcare; Institutional |
Hard Nonporous (HN); Food Contact Post-Rinse Required (FCR) |
1.0 minutes |
Solid |
SARS-CoV-2 |
2021-08-24 |
Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
| 1314 |
87508-3 |
Increased Risk |
Sodium chlorite |
Performacide |
Odorstart LLC |
Healthcare; Institutional |
Hard Nonporous (HN) |
0.5 minutes |
Dilutable |
SARS-CoV-2 |
2021-06-08 |
Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
| 2643 |
91603-3 |
Increased Risk |
Quaternary ammonium; Sodium chlorite |
RD286 |
Aseptic Health LLC |
Hospital, Institutional, Residential |
Hard Nonporous (HN) |
0.25 minutes |
Ready-to-use |
SARS-CoV-2 |
2023-09-25 |
Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |